Clinical Trial Update: Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection [Phase 3]

View source ↗

Summary

A phase 3 clinical trial completed evaluating the efficacy and safety of adding Enfuvirtide to an Optimized Background Antiretroviral Regimen in treatment-exper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Enfuvirtide (enfuvirtide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: HIV Infections | Phase 3 | Status: COMPLETED